Conventional dose intensive immunochemotherapy regimen in an adult patient with very late relapse of Burkitt's lymphoma

J Chemother. 2007 Apr;19(2):236-8. doi: 10.1179/joc.2007.19.2.236.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Burkitt Lymphoma / drug therapy*
  • Child, Preschool
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Humans
  • Male
  • Methotrexate / therapeutic use
  • Prednisone / therapeutic use
  • Recurrence
  • Rituximab
  • Vincristine / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
  • Methotrexate

Supplementary concepts

  • MEVAP protocol